Stay updated on Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial page.

Latest updates to the Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe record presents details for a pediatric study of ruxolitinib cream for atopic dermatitis, including eligibility criteria, study locations, treatment cohorts, outcomes, and completion status.SummaryDifference61%

- Check10 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden rather than the study record.SummaryDifference0.2%

- Check17 days agoChange DetectedAn NIH announcement banner about the website transition and terminology appears above the unavailable study record.SummaryDifference1%

- Check24 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1; the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. This reflects an access issue rather than a substantive update to study information.SummaryDifference19%

Stay in the know with updates to Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial page.